SparingVision, a clinical-stage genomic medicine company developing vision-saving treatments for eye diseases, today announced that it has sold its ex vivo GIRK technology to Tenpoint Therapeutics.
Read moreAn agreement between the University of Barcelona spin-off DBGen Ocular Genomics and the company Novartis España will enable the genetic identification of retinitis pigmentosa (RP) and Leber congenita...
Read moreEl tratamiento con L-Ergotioneina consigue incrementar la solubilidad de la cistina en la orina, evitando así la formación de cálculos o retrasando su aparición.
Read moreUna estrategia basada en nanopartículas lipídicas cargadas con ARN mensajero permite editar, in vivo, en el propio organismo, el genoma de las células madre hematopoyéticas. La aproximación, prob...
Read moreA team from the University of Barcelona has described how the lack of the CERKL gene alters the ability of retinal cells to fight oxidative stress generated by light and triggers cell death mechanisms...
Read moreAM-Pharma B.V. today announced positive clinical results from the Phase 1b study evaluating the company’s proprietary recombinant alkaline phosphatase, ilofotase alfa, as potential enzyme replacemen...
Read moreInvestigadores de la Universidad de Virginia han identificado nuevos genes relacionados con la calcificación de las arterias coronarias así como dianas para el desarrollo de tratamientos para esta c...
Read moreSpark secures exclusive worldwide rights to SpliceBio’s proprietary Protein Splicing platform to develop, manufacture, and commercialize a gene therapy targeting an undisclosed inherited retinal dis...
Read moreSpliceBio is pleased to announce the signing of an exclusive collaboration and licensing agreement with Spark Therapeutics to utilize SpliceBio’s proprietary Protein Splicing platform to develop a g...
Read moreThe group has applied these classification recommendations to 128 variants reported in the literature and/or public databases, classifying 17 as pathogenic variants, and another 17 as benign.
Read moreLas enfermedades mitocondriales son monogénicas, es decir, causadas por mutaciones en un solo gen. Actualmente, se conocen unas 400 enfermedades mitocondriales distintas.
Read moreScientists have managed to expand their precision medicine platform, allowing a detailed study of tumors of the nervous system.
Read more